News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Quest Diagnostics, a provider of diagnostic information services, has announced that its AAVrh74 ELISA assay (CDx) has been granted breakthrough device designation from the U.S. Food and Drug Administration (FDA).
Optibrium, a developer of software and AI solutions for drug discovery, has acquired BioPharmics in a view to expand its 3D drug design and modelling offering.
With the rise of mRNA-based treatments, the field of oncology is about to go through a significant change.